Merck beats revenues assumptions, rears purchases outlook on solid need for leading drugs like Keytruda - CNBC

.Merck trumps profits requirements, rears sales expectation on strong need for best medications like Keytruda CNBCMerck &amp Co. (MRK US) Beats Income Estimates as Keytruda Sales Surge BloombergMerck Inventory: Pharma Titan Posts Sturdy Outcomes, Yet Expectation Drops Short Investor's Service DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck trumps earnings as well as purchases requirements amid Keytruda asset, yet supplies mixed full-year overview MarketWatch.